Q1 2013 Earnings Call

May 20, 2013 9:00 PM ET

Executives

Oasis Qui – IR Officer

Chunlin Wang – CEO

Peng Ge – CFO

Analysts

Christy He – Morgan Stanley

Andy Nahas – Prospect Fund

Presentation

Operator

Thank you for standing by for CNinsure's first quarter 2013 earnings conference call. At this time all participants are in a listen-only mode. (Operator Instructions) For your information, this conference call is now being broadcasted live over the internet. Webcast replay will be available within 90 minutes after the conference is finished. Please visit the CNinsure IR website at ir.cninsure.net under the events and webcasts section. Today’s conference is being recorded. If you have any objections you may disconnect at any time.

At this time I would now like to turn the meeting over to your host for today’s conference Ms. Oasis Qui, CNinsure's investor relations officer.

Oasis Qui

Welcome

Zoom Technologies, Inc. (ZOOM)

Q1 2013 Earnings Call

May 20, 2013 06:00 pm ET

Executives

Patrick Wong – Vice President-Corporate Finance

Anthony K. Chan – Chief Financial Officer & Director

Presentation

Operator

Ladies and gentlemen, thank you for standing by and welcome to the Q1 2013 Conference Call. At this time, all participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session. (Operator Instructions) I must advice you that this conference is being recorded today, Tuesday the 21^st of May 2013.

Now I’d like to hand the conference over to your speaker today, Mr. Patrick Wong, Vice President of Corporate Finance. Thank you, please go ahead.

Patrick Wong

Thank you operator. Thank you for joining Zoom Technologies for its first quarter 2013 earnings conference call. My name is Patrick Wong, Vice President of Finance. Welcome back everybody. We will recap our results

Q4 2013 Earnings Call

May 20, 2013 5:00 pm ET

Executives

Andy Giesler - Vice President of Finance

Dennis L. May - Chief Executive Officer, President and Director

Jeremy J. Aguilar - Chief Financial Officer, Principal Accounting Officer and Corporate Secretary

Analysts

Daniel T. Binder - Jefferies & Company, Inc., Research Division

Michael Lasser - UBS Investment Bank, Research Division

Gregory S. Melich - ISI Group Inc., Research Division

Bradley B. Thomas - KeyBanc Capital Markets Inc., Research Division

David S. Strasser - Janney Montgomery Scott LLC, Research Division

Christopher Horvers - JP Morgan Chase & Co, Research Division

David A. Schick - Stifel, Nicolaus & Co., Inc., Research Division

Brian W. Nagel - Oppenheimer & Co. Inc., Research Division

David G. Magee - SunTrust Robinson Humphrey, Inc., Research Division

Peter J. Keith - Piper Jaffray Companies, Research Division

Gary Balter - Crédit Suisse AG, Research Division

Presentation

Q1 2014 Earnings Call

May 20, 2013 5:00 pm ET

Executives

Oona McCullough - Director of Investor Relations

Francis J. Conforti - Chief Financial Officer, Chief Accounting Officer and Controller

David W. McCreight - Chief Executive Officer of Anthropologie Group

Richard A. Hayne - Co-Founder, Chairman of the Board of Directors, Chief Executive Officer and President

Tedford G. Marlow - Chief Executive Officer of Urban Outfitters Group

David Hayne

Analysts

Kimberly C. Greenberger - Morgan Stanley, Research Division

Janet Kloppenburg

Adrienne Tennant - Janney Montgomery Scott LLC, Research Division

Lindsay Drucker Mann - Goldman Sachs Group Inc., Research Division

Lorraine Maikis Hutchinson - BofA Merrill Lynch, Research Division

Marni Shapiro - The Retail Tracker

Paul Lejuez - Wells Fargo Securities, LLC, Research Division

Matthew McClintock - Barclays Capital, Research Division

Erika K. Maschmeyer - Robert W. Baird & Co. Incorporated, Research Division

Oliver Chen - Citigroup Inc,

Macquarie Infrastructure Company LLC. (MIC)

2013 Annual Shareholder Meeting Conference Call

May 20, 2013 5:30 pm ET

Executives

Jay Davis – Managing Director, Investor Relations

John Roberts – Chairman

Michael Kernan – General Counsel and Corporate Secretary

Presentation

Jay Davis

Good afternoon, welcome to the Macquarie Infrastructure Company Annual Meeting of Shareholders. I am Jay Davis, Head of Investor Relations for the Company. Before turning the proceedings over to the Chairman of the MIC Board of Directors, let me remind you that this presentation by Macquarie Infrastructure Company is proprietary and all rights are reserved. Any recording, rebroadcast or other use of this presentation in whole or in part without the prior written consent of Macquarie Infrastructure Company is prohibited.

Today’s presentation has been prepared solely for information purposes, it is not a solicitation of an offer to buy or sell any security or instrument. You may have questions for

Q1 2014 Earnings Call

May 20, 2013 5:00 pm ET

Executives

Derrick Nueman - Investor Relations Executive

Thomas S. Rogers - Chief Executive Officer, President and Director

Naveen Chopra - Chief Financial Officer and Senior Vice President of Corporate Development & Strategy

Matthew Zinn - Chief Privacy Officer, Senior Vice President, General Counsel and Corporate Secretary

Analysts

Michael J. Olson - Piper Jaffray Companies, Research Division

David W. Miller - Caris & Company, Inc., Research Division

Anthony Wible - Janney Montgomery Scott LLC, Research Division

Todd T. Mitchell - Brean Capital LLC, Research Division

Brian Patrick Fitzgerald - Jefferies & Company, Inc., Research Division

Barton E. Crockett - Lazard Capital Markets LLC, Research Division

Richard Tullo - Albert Fried & Company, LLC, Research Division

Perry Huang - Goldman Sachs Group Inc., Research Division

Daniel Ernst - Hudson Square Research, Inc.

Alan S. Gould - Evercore Partners Inc., Research

14th Annual B. Riley & Co. Investor Conference Transcript

May 20, 2013 5:00 PM ET

Executives

Michael Moe - Chairman, President and CEO

Analysts

Presentation

Unidentified Analyst

Yeah. So, I’ll do quick intro. GSV Capital, ticker is GSVC. And we have here Michael Moe, if you recollect, he is the person who call [Sorbert] called back in ’80. And GSV Capital, they make investments in pre-IPO, VC-backed companies. We just saw Keating Capital, so I guess, it will be interesting how this contrast with it.

And with that, I’ll hand over to you.

Michael Moe

Great. Thanks so much, [Jeff]. So, [Tim], coming out here, it seems like he was in one piece, so maybe like him have equal success, so it will be good. So in terms of GSV, just quickly, GSV stands for Global Silicon Valley. We are based in the heart of Silicon

UBS Global Healthcare Conference

May 20, 2013 04:00 PM ET

Executives

Stephen Schwartz - President and CEO

Martin Headley - EVP and CFO

Analysts

Melanie San - UBS (ph)

Presentation

Melanie San - UBS

Alright good afternoon everyone. Thank you for making it out to our last session of the day. And it’s Melanie San, happy to be your host for this session. Our next presenter will be Stephen Schwartz President and CEO and Martin Headley EVP and CFO of Brooke Automation. Thank you.

Stephen Schwartz

Thank you Malone good afternoon. We really appreciate your time today. Today I would like to introduce in a little bit more detail the trust that Brooks has in Life Sciences System space. I will begin by talking generally about the company and the business, and talk very specifically then about the market opportunity and our approach to the Life

UBS Global Healthcare Services Conference Call

May 20, 2013 3:00 pm ET

Executives

Bruce J. Mackey, Jr. – President and Chief Executive Officer

Paul V. Hoagland – Treasurer and Chief Financial Officer

Analysts

Melanie Fan – UBS

Presentation

Melanie Fan – UBS

Good afternoon everyone. We’re going to get started. My name is Melanie Fan, I’m happy to be your host for this session. Our next presenter is Bruce Mackey, the President and CEO; and Paul Hoagland, Treasurer and CFO of Five Star Quality Care. There is going to be a breakout session following this presentation across the hall and Carnegie. Thanks.

Bruce J. Mackey, Jr.

Great, thanks Melanie. I appreciate that and thank you all for being here this afternoon. By many measures Five Star makes the strong case of a solid investment opportunity. We’re one of the largest operators of senior living

Q1 2013 Earnings Call

May 20, 2013 5:00 pm ET

Executives

Christopher P. Lowe - Chief Financial Officer, Principal Accounting Officer and Chief Business Officer

Paul F. Truex - Chief Executive Officer, President and Director

Colin Hislop - Chief Medical Officer and Senior Vice President

Analysts

Marko K. Kozul - Leerink Swann LLC, Research Division

Christopher Mortko

Edward A. Tenthoff - Piper Jaffray Companies, Research Division

Heather Behanna - JMP Securities LLC, Research Division

Presentation

Operator

Good day, ladies and gentlemen, and thank you for standing by, and welcome to the Anthera's First Quarter Corporate Update Conference Call. [Operator Instructions] I would now like to turn the call over and introduce Chris Lowe, Anthera's Chief Business Officer and Chief Financial Officer. You may begin the conference.

Christopher P. Lowe

Thank you, everyone, for joining us this afternoon. Welcome to Anthera's First Quarter Corporate Update Call. We issued

Q1 2013 Earnings Call

May 20, 2013 5:00 p.m. ET

Executives

Kexuan Yao - Chairman and CEO

Philip Rosen - The Language Factor

Analysts

[Unidentified Analyst]

Presentation

Operator

Good afternoon ladies and gentlemen. Thank you for standing by. Welcome to the China Armco Metals first quarter 2013 earnings conference call. (Operator Instructions) This conference is being recorded today May 28, 2013. I’d like to turn the conference over to Philip Rosen of The Language Factor. Please go ahead Mr. Rosen.

Philip Rosen

Thank you and welcome everyone to today’s conference call for China Armco Metals. This call will cover China Armco’s financial and operating results for the first quarter of 2013. The earnings press release accompanying this conference call went to the wire on May 15, 2013. On our call today, Mr. Kexuan Yao, Chairman and CEO, Mr. Fengtao Wen, Chief Financial Officer, Mr. [Li

May 20, 2013 3:30 pm ET

Executives

Rajesh C. Shrotriya - Chairman, Chief Executive Officer, President, Chairman of Placement Committee and Chairman of Product Acquisition Committee

Analysts

Melanie Fan

Presentation

Melanie Fan

Hi, good afternoon, everyone. My name is Melanie Fan, I'm happy to be your host for this session. Our next presenter is Raj Shrotriya, the Chairman, President and CEO of Spectrum Pharmaceuticals.

We will have a breakout session immediately following this presentation across the hall in Carnegie's. Thank you.

Rajesh C. Shrotriya

Melanie, thank you very much. I represent a small company based on the West Coast called Spectrum Pharmaceuticals. We are focused on oncology.

But before I start my presentation today, let me remind you to read our Safe Harbor statement. Please note that I will be making forward-looking statements regarding future events and performance, and the actual results may materially differ from

UBS Global Healthcare Conference

May 20, 2013 02:30 PM ET

Executives

Jim Daly - EVP AND CCO

Paul Friedman - President and CEO

Analysts

Matt Roden - UBS

Presentation

Matt Roden - UBS

Good afternoon everyone. My name is Matt Roden. I'm one of the Biotech analysts here at UBS and I'd like to thank everyone for attending the new UBS Global Healthcare Conference. I'm pleased and privileged to introduced Incyte, a market leader in achieving myelofibrosis and related conditions. Incyte successfully launched its first major product Jakafi about a year and half ago and looks forward to several pipeline readouts over next year.

We have two speakers presenting on behalf of Incyte today. First we have the Executive Vice President and Chief Commercial Officer Jim Daly and he is going to be followed by the President and Chief Executive Officer, Paul Friedman. And I would remind

Q1 2013 Earnings Call

May 20, 2013, 04:30 pm ET

Executives

Valter Pinto - Alliance Advisors, LLC

Frederic Scheer - Chairman & CEO

Michael Okada - SVP & CFO

Analysts

Jason D'Amico - JPMorgan Chase

Presentation

Operator

Good afternoon ladies and gentlemen. Thank you for standing-by. Welcome to the Cereplast 2013 First Quarter Financial Results Conference Call. During today’s presentation, all participants will be in a listen-only mode. Following the presentation, the conference will be opened for questions. (Operator Instructions) This conference is being recorded today, May 20, 2013.

I would now like to turn the conference over to Valter Pinto from Alliance Advisors. Please go ahead, sir.

Valter Pinto

Thank you. Good afternoon, and welcome to the Cereplast 2013 first quarter financial results conference call. With us today is, Frederic Scheer, Chairman and CEO and Michael Okada, Chief Financial Officer.

Before I introduce the speakers, I

May 20, 2013 3:30 pm ET

Executives

James S. J. Manuso - Chairman of The Board and Chief Executive Officer

Presentation

Unknown Analyst

Good afternoon, everyone, and thank you so much for coming to the 2013 UBS Global Healthcare Conference. My name is Terrence Hu, and I'm very happy to be your host for this session. It is my pleasure to introduce our next presenter, Dr. James Manuso, Chairman and CEO of Astex Pharmaceuticals. There will be a breakout session at Carnegie West [ph], just across the hall, immediately following this session. Thank you very much

James S. J. Manuso

Thank you very much, and thanks so much to the folks at UBS for inviting us, and thank you for joining us today. Looking forward to telling you about Astex and giving you an update. And in that regard, of course, I'll be making some forward-looking

May 20, 2013 11:00 am ET

Executives

Philip J. Hawk - Executive Chairman, Chief Executive Officer and Chairman of Executive Committee

Ted W. Owen - Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Treasurer

Peter W. Wallace - Chief Operating Officer and Executive Vice President

Analysts

Richard Wesolowski - Sidoti & Company, LLC

Lee Jagoda - CJS Securities, Inc.

Tahira Afzal - KeyBanc Capital Markets Inc., Research Division

Stephen Ragard - Stephens Inc., Research Division

Adam R. Thalhimer - BB&T Capital Markets, Research Division

Tristan Richardson - D.A. Davidson & Co., Research Division

Presentation

Operator

Good day, ladies and gentlemen, and welcome to the Team, Inc. Quarter 4 2013 Earnings Guidance Call.

My name is Matthew, and I will be your operator for today. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. And now, I would like to turn the

May 20, 2013 9:30 am ET

Executives

Deanne Gabel - Director of Investor Relations

B. Ben Baldanza - Chief Executive Officer, President and Director

Edward M. Christie - Chief Financial Officer and Senior Vice President

Barry L. Biffle - Chief Marketing Officer and Executive Vice President

Misty Pinson - Director of Corporate Communications

Analysts

Helane R. Becker - Cowen Securities LLC, Research Division

James D. Parker - Raymond James & Associates, Inc., Research Division

John D. Godyn - Morgan Stanley, Research Division

Hunter K. Keay - Wolfe Research, LLC

Stephen O'Hara - Sidoti & Company, LLC

Michael Linenberg - Deutsche Bank AG, Research Division

Duane Pfennigwerth - Evercore Partners Inc., Research Division

Bob McAdoo - Imperial Capital, LLC, Research Division

Stephen Trent - Citigroup Inc, Research Division

David E. Fintzen - Barclays Capital, Research Division

Presentation

Deanne Gabel

Well, good morning, and welcome to Spirit Airlines 2013

The Electrical Products Group 2013 Annual Spring Conference

May 20, 2013 14:00 ET

Executives

David Meline – Chief Financial Officer

Analysts

Presentation

Operator

Hi everybody if you guys could take a seat that would be great. We just have our last few presentations of the day. I’m pleased to welcome David Meline, CFO of 3M who has been back to EPG now for few times.

David Meline

Okay. Thank you very much. What I’m going to go through today is primarily what I’m going to cover is some of the key themes that we came out with late last year, which was basically the work we did to develop our sort of next stage plan under the new CEO Inge Thulin. So we spent last year working through that and rolled it towards year end, some of you were there. So I’m going to go through, it's

Q1 2013 Earnings Call

May 20, 2013 11:03 AM ET

Executives

Solomon Lee - Chairman and CEO

Analysts

Presentation

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the Sino Agro Food Incorporated first quarter 2013 Results Conference Call. At this time all participants are in a listen-only mode. Later there will be an opportunity for questions and comments and instructions will be given at that time. As a reminder this call is being recorded.

I would now like to turn the conference call over to our host. Mr. Solomon Lee, Chief Executive Officer and Chairman of Sino Agro Foods. Solomon, please go ahead.

Solomon Lee

Thank you Christie, and thank you everyone who is attending today’s conference call. I would like to now take the opportunity to read to you a statement from the Company regarding quarter 1, 2013 results. The Company set

May 20, 2013 1:00 pm ET

Executives

David T. Hung - Chief Executive Officer, President and Executive Director

Analysts

Matthew Roden - UBS Investment Bank, Research Division

Presentation

Matthew Roden - UBS Investment Bank, Research Division

Good afternoon, everyone. My name is Matt Roden. I'm one the biopic analysts here at UBS. I'd like to thank everyone for attending the new UBS Global Healthcare Conference. I'm pleased and privileged to be introducing Medivation, an emerging leader in the treatment of prostate cancer. As you'll year, Medivation has successfully launched its first product, XTANDI, and looks forward to the release of Phase III clinical trial data later this year in expanding the treatment benefit of XTANDI to a broader audience of prostate cancer patients. Speaking on behalf of Medivation is its Chief Executive Officer, David Hung. Dr. Hung has served in this role since 2003, and prior health